Waaree Energies falls 5.6% after CBP order 2026

Stock slides as US customs determination triggers worries

Waaree Energies shares declined 5.55% to Rs 2,842.50 on Monday after a determination by the U.S. Customs and Border Protection (CBP) triggered concerns around exports to the United States. The stock also fell as much as 4.95% in intraday trade before recovering some losses to trade 3.3% lower, even after the company issued a clarification. The market reaction centred on uncertainty around an investigation tied to alleged evasion of anti-dumping and countervailing duties. Investors focused on whether the findings could widen beyond a narrow set of past shipments. Waaree said the interpretation in some media reports was “misread and overdone”. The company maintained that the issue does not pose a material risk to its business. It reiterated there has been no disruption to its US operations, manufacturing, customer deliveries, or commercial activities.

What the CBP looked into and the date of the determination

The clarification followed a CBP determination issued on 23 June 2026. The investigation concerned allegations of evasion of anti-dumping and countervailing duties that apply in the US to Chinese crystalline silicon solar cells and modules. Waaree said the determination related to a limited set of historical import entries. The company also said the scope does not extend to its broader US business or overall export operations. Separately, another report cited that CBP had launched an investigation into Waaree Energies and its US subsidiary Waaree Solar Americas, following a complaint from the American Alliance for Solar Manufacturing Trade Committee (AASMTC). That report also mentioned temporary measures citing “reasonable suspicion” of tax evasion on goods sent to the US. Waaree’s public messaging, however, focused on what CBP did and did not conclude in the determination.

Waaree’s key clarification: no finding of Chinese-origin cells

Waaree said the CBP investigation did not find that it had exported solar modules made using Chinese-origin solar cells to the United States. According to the company, US Customs officials inspected its manufacturing facility in India and confirmed that no Chinese-origin solar cells were used in the shipments under review. Waaree said the core allegation was not substantiated. It added that CBP expressly confirmed Waaree fully cooperated throughout the investigation. The company said CBP drew no adverse inference against it. Waaree also said CBP declined the petitioner’s request to make an evasion finding covering all of its imports. It said the determination was limited to a narrow subset of historical import entries and has no impact on ongoing manufacturing, customer deliveries, or commercial operations.

Why the company says operations remain unaffected

Waaree reiterated that its US business continues to operate normally. It said there has been no disruption to its US operations, manufacturing, customer deliveries, or commercial activities. The company framed the issue as limited in scope and historical in nature. It also stated that authorities have not imposed charges across all imports, indicating the matter remains narrow. Waaree repeated its position that it remains committed to regulatory compliance, transparency, and governance. The company’s exchange filing underlined that the decision is not final. Management indicated it is evaluating next steps under applicable US law. Waaree said it is working with its US trade counsel on available remedies.

Not final: legal remedies and review options

Waaree stated that the CBP determination is not a final adjudication. It said it is evaluating all available legal remedies, including administrative and judicial review. In an exchange filing, the company said that under applicable US law it has the right to seek a de novo administrative review and, thereafter, judicial review before the US Court of International Trade. The statement was attributed to Jignesh Rathod, whole-time director and chief executive officer, Waaree Energies. The company positioned these steps as part of a structured process rather than an immediate business disruption. Waaree also highlighted that CBP confirmed its cooperation throughout the investigation. The firm’s messaging aimed to separate legal process from day-to-day operations. For investors, the key question now is how any review process affects retrospective duties, if any, and timelines.

Brokerage view: limited downside but watch retrospective duties

A brokerage note said the downside appears limited. It cited that CBP confirmed Waaree had sufficient non-Chinese solar cell production to support its US shipments. The brokerage also noted CBP did not apply a blanket adverse-inference ruling. It added that CBP restricted its findings to certain historical import entries linked to Vietnam and Malaysia. The brokerage retained its ‘Add’ rating on the stock with a target price of Rs 3,185. It said key monitorables include the quantum of any retrospective duties. It also flagged the outcome of Waaree’s administrative or judicial appeal as a key variable. Another monitorable cited was any spillover impact from pending anti-dumping and countervailing duty proceedings covering India-origin solar imports.

Tariff headlines: management says 126% rate not applicable

Separately, the company’s management reassured investors that a US 126% tariff order would not have a material impact on Waaree Energies’ earnings. The order stated that duties are contingent upon the country of origin of the solar cells used in modules supplied to the US. Management said the 126% rate does not apply to Waaree because the company does not use solar cells manufactured in India for its US supplies. It also said that selling prices do not necessarily increase by 126%, and the duty changes based on which cells are used for exports. Waaree told Reuters it expected no material impact due to the solar tariffs. The company said exports from India to the US were continuing, even as it builds local capacity. The statement focused on supply-chain sourcing and compliance rather than forecasting demand.

Capacity context: US footprint and India’s module supply

In an interview excerpt, Waaree’s Group Head for Finance said the company had 1.6 gigawatt US capacity. The same remarks also indicated a total of 4.2 gigawatt capacity is expected early next year. Management said this local manufacturing footprint helps insulate the business from import restrictions or tariffs. In India, the broader industry context shows significant supply capacity. As of January 2026, India had installed solar-module manufacturing capacity of more than 160 GW, compared with domestic demand of 40-45 GW. That gap has been a key backdrop for export-led growth strategies across the sector. Some commentary also flagged the possibility of global oversupply pressuring margins beyond FY29-30, though Waaree’s clarification was focused on near-term regulatory interpretation and continuity of operations. The immediate market focus remains on the CBP process and any retrospective duties linked to historical entries.

Key facts at a glance

Market impact and why this matters for investors

The immediate impact showed up in Waaree’s share price, as markets reacted to regulatory uncertainty rather than reported disruption to operations. Waaree’s clarification attempted to reduce the perceived risk by emphasising the narrow scope of the determination and the absence of an adverse inference. The brokerage commentary similarly pointed to the lack of a blanket ruling and the limitation to historical entries, which can cap near-term downside if no broader action follows. At the same time, the monitorables listed by the brokerage keep attention on retrospective duties, because those can affect cash flows and reported profitability if imposed. The legal path described by Waaree suggests the matter may extend through administrative and judicial review stages, which can influence timelines for final outcomes. The 126% tariff discussion adds another layer, but management’s position is that the rate is not applicable based on cell-origin for its US supplies. Capacity disclosures about the US footprint indicate the company is positioning to serve the market with local manufacturing as well as exports. For the sector, the episode underscores how origin rules, documentation, and compliance processes can move stocks quickly even when companies state that shipments and deliveries continue as usual.

Conclusion

Waaree Energies’ stock fell sharply after a CBP determination raised concerns about its US exports, but the company said the investigation found no evidence of Chinese-origin solar cells in the reviewed shipments and that operations remain unaffected. Waaree also said the findings were limited to a narrow set of historical entries and that CBP drew no adverse inference while declining a request for an evasion finding across all imports. A brokerage retained an ‘Add’ rating and a Rs 3,185 target but flagged retrospective duties and appeal outcomes as key monitorables. Next steps depend on how the company pursues administrative review and, if required, judicial review before the US Court of International Trade, along with any developments in related AD/CVD proceedings covering India-origin solar imports.